By Marc-André Gagnon Canada’s healthcare system, Canadian healthcare system, Canadian medicare, cost of drugs, drug cost, Drug coverage, employee benefits, health care spending, national drug plan, Pharmaceutical, Quebec, Quebec healthcare
In spite of very high expenditures for drug coverage, one in 10 Canadians cannot afford to fill their prescriptions. The current patchwork of public and private plans across the country means that Canadians are covered for their prescription drugs based on where they live or work, rather than on their medical needs.
By Mélanie Meloche-Holubowski Canadian health care, Canadian researchers, evidence-based research, Health journalism, Health policy, public engagement
In a time when many government scientists in Canada are being muzzled, talking to the media may be a scary prospect for many researchers. Yet some academics are calling on their peers to have their voices heard in the media and cut through the noise coming from think tanks and lobbyists.
By expert, gagging scientists, journalism, journalist, média, Podcasts, research, researcher, scientist
Talking to the media for a scientist may be a scary prospect. Yet some are calling on their peers to have their voices more often heard in the media in order to counter balance the voices of think tanks and lobbyists.
By Ryan Meili Canada’s healthcare system, Health care costs, health service funding, healthy communities, Homelessness in Canada, Social inequality, social programs
Recently, I was fortunate to attend the Global Symposium on the Role of Physicians and National Medical Associations in Addressing Health Equity and the Social Determinants of Health held in London, England.
By assurance médicament, assurance privée, assurance publique, assurance-maladie, Canada, coût des médicaments, Médicament, OCDE, Podcasts
Les régimes privés sont généralement inefficaces et coûtent au-delà de 5 milliards de dollars chaque année aux entreprises. Pourquoi les entreprises et les assureurs acceptent-ils autant de gaspillage?
By Alan Cassels and Sean O'Brady assurance, assurance-médicaments, assureur, coût des médicaments, médicaments, prescription, régime privé, régime public d'assurance-médicaments, régimes
Il existe beaucoup de gaspillage au sein des systèmes de santé, mais un aspect qui semble avoir échappé à cette analyse est le gaspillage dans les assurances-médicaments privées au Canada. Estimés à plus de 5 milliards par année, cela représente la moitié des dépenses annuelles des prescriptions payées par les assureurs privés canadiens.
By Marc-André Gagnon assurance médicament, Commissaire de la santé et au bien-être du Québec, coût des médicaments, facturation des ordonnances, médicament générique, médicaments, ordonnance, pharmacie, Quebec, RAMQ, régime privé, régime public, régime public universel d’assurance-médicaments, substitution générique obligatoire
Pour soigner une laryngite, mon fils s’est fait prescrire un antibiotique. Le prix du produit est normalement 11,85$, auquel il faut ajouter les honoraires professionnels du pharmacien. Mon régime privé d’assurance-médicaments couvre 80% de mes dépenses et je m’attendais donc à payer 4,40$ en coassurance. J’ai toutefois dû payer 47,89$. Bienvenue dans le monde surréaliste de l’assurance-médicaments du Québec!
By Alan Cassels and Sean O'Brady cost of drugs, drug plan, employee drug benefits, Pharmacare, Pharmaceutical industry, pharmaceutical policies in Canada, prescription drugs, private drug plans, Private health benefits, public drug plan
There is certainly a lot of waste in health systems, but one area that seems to have escaped close scrutiny is the waste in private drug plans in Canada. To put it simply, that waste is gut-churning.
By Marc-André Gagnon coût des médicaments, coût par habitant en médicaments d’ordonnance, FCSII, Industrie pharmaceutique, médicament ordonnance, médicaments génériques, OCDE, politiques pharmaceutiques au Canada, régime d’assurance-médicaments national
Alors que le Canada figure parmi les pays de l’Organisation de coopération et de développement économiques (OCDE) dont le coût par habitant en médicaments d’ordonnance est le plus élevé, un Canadien sur dix est incapable de se procurer des médicaments d’ordonnance pour des raisons financières.
By Marc-André Gagnon cost of drugs, drug plan, national drug plan, Pharmacare, Pharmaceutical industry, pharmaceutical policies in Canada, prescription drugs, Private health benefits, universal pharmacare
Canadians pay among the highest costs per capita among OECD countries for prescription drugs, with one Canadian out of 10 unable to fill their prescriptions because of financial reasons.